As vice president of Heron Therapeutics, Erol Onel works with a team responsible for seeking approval for a long-acting non-opioid pain drug. Possessing more than a decade of experience in clinical research, Erol Onel has successfully engaged with the US Federal Drug Administration on several occasions and is familiar with all phases of a clinical trial, as outlined below.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly